𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Donepezil beneficial in mild-to-moderate Alzheimer's disease

Book ID
120865219
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2001
Weight
137 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effect of donepezil on emergence of apat
Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease
✍ Gunhild Waldemar; Serge Gauthier; Roy Jones; David Wilkinson; Jeffrey Cummings; πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 193 KB πŸ‘ 2 views

To determine whether donepezil treatment (10 mg/day over 24 weeks) is associated with delayed emergence of apathy in patients with mild to moderate Alzheimer's disease (AD) and to explore relationships between donepezil's effects on apathy and other Neuropsychiatric Inventory (NPI)measured behaviour

Cost-effectiveness analysis of donepezil
Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer's disease in Taiwan
✍ Jong-Ling Fuh; Shuu-Jiun Wang πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 2 views

## Abstract ## Background Donepezil is a drug used for treatment in patients with Alzheimer's disease (AD). Information regarding the cost‐effectiveness of this medication was previously rare in Asia. We used techniques of decision analysis and economic evaluation in conjunction with available loc